Brahen L S, Henderson R K, Capone T, Kordal N
J Clin Psychiatry. 1984 Sep;45(9 Pt 2):49-52.
Inmates with a history of opiate addiction have traditionally been excluded from jail work-release programs because of their high likelihood of returning to drug use. In 1972, a new jail work-release program was begun in the Nassau County (New York) Jail, to which addicted inmates, who had formerly been excluded automatically, could request admission if they took the opiate blocking agent naltrexone. Inmates received naltrexone twice a week and had routine urine checks for drugs of abuse and an alcohol breath test when indicated. Psychological and vocational testing and weekly psychotherapy sessions were provided. For those no longer incarcerated, the adjacent hospital outpatient clinic was available for naltrexone treatment. Naltrexone has proved to be a completely effective opiate blocking agent with no major side effects in 691 patients over a 10-year period.
有阿片类药物成瘾史的囚犯传统上被排除在监狱工作释放项目之外，因为他们很有可能再次吸毒。1972年，纽约州拿骚县监狱启动了一项新的监狱工作释放项目，以前被自动排除在外的成瘾囚犯，如果服用阿片类阻滞剂纳曲酮，就可以申请进入该项目。囚犯每周接受两次纳曲酮治疗，并在必要时进行常规尿液滥用药物检查和酒精呼气测试。还提供心理和职业测试以及每周一次的心理治疗课程。对于那些不再被监禁的人，可以在相邻的医院门诊接受纳曲酮治疗。在10年时间里，纳曲酮已被证明是一种完全有效的阿片类阻滞剂，对691名患者没有重大副作用。
